SPDR S&P Biotech ETF (XBI) experienced an approximate $449.1M outflow, a 5.9% decline in shares outstanding week-over-week. This was a standout outflow among ETFs covered by ETF Channel, signaling modest investor risk-off positioning away from biotech exposure.
SPDR S&P Biotech ETF (XBI) experienced an approximate $449.1M outflow, a 5.9% decline in shares outstanding week-over-week. This was a standout outflow among ETFs covered by ETF Channel, signaling modest investor risk-off positioning away from biotech exposure.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly negative
Sentiment Score
-0.15
